HATTERAS VENTURE PARTNERS
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
HATTERAS VENTURE PARTNERS
Social Links:
Industry:
Financial Services Medical Venture Capital
Founded:
2000-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Amasia
Amasia is a venture capital investment firm that invests from Seed to Series B stages.
Charlotte Angel Partners
Charlotte Angel Partners is a North Carolina-based venture capital fund that assists and funds early stage companies.
VentureFriends
VentureFriends is a venture capital fund that invests in tech-enabled companies.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Code Biotherapeutics | Hatteras Venture Partners investment in Series A - Code Biotherapeutics | 75 M USD |
| 2022-03-08 | Wildflower Health | Hatteras Venture Partners investment in Venture Round - Wildflower Health | 26 M USD |
| 2022-02-07 | Huma.AI | Hatteras Venture Partners investment in Series A - Huma.AI | 9.5 M USD |
| 2022-01-07 | AN2 Therapeutics | Hatteras Venture Partners investment in Series B - AN2 Therapeutics | 80 M USD |
| 2021-12-02 | Tune Therapeutics | Hatteras Venture Partners investment in Series A - Tune Therapeutics | 40 M USD |
| 2021-12-01 | Trefoil Therapeutics | Hatteras Venture Partners investment in Series A - Trefoil Therapeutics | 28 M USD |
| 2021-11-08 | GeneCentric Therapeutics | Hatteras Venture Partners investment in Series B - GeneCentric Therapeutics | 7.5 M USD |
| 2021-10-19 | GoCheck | Hatteras Venture Partners investment in Venture Round - GoCheck | 10 M USD |
| 2021-09-24 | Elligo Health Research | Hatteras Venture Partners investment in Series E - Elligo Health Research | 135 M USD |
| 2021-09-08 | Qvella Corporation | Hatteras Venture Partners investment in Venture Round - Qvella Corporation | N/A |